News

Molson Coors Beverage Company TAP has made premiumization a central pillar of its long-term growth strategy, aiming to enhance margins and consumer appeal. The company is actively shifting its

Rocket Pharmaceuticals RCKT announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its investigational adeno-associated virus (AAV)-based gene therapy

Danaher Corporation DHR is scheduled to release second-quarter 2025 results on July 22, before market open.The Zacks Consensus Estimate for revenues is pegged at $5.84 billion, which indicates an

Units of Energy Transfer LP ET have rallied 1.5% in the past three months compared with the Zacks Oil and Gas - Production Pipeline - MLB industry’s growth of 0.2%. The oil and gas midstream firm

Huntington Bancshares Incorporated HBAN reported second-quarter 2025 adjusted earnings per share (EPS) of 38 cents, which matched the Zacks Consensus Estimate. In the prior-year quarter, the company

Alphabet GOOGL is set to report second-quarter 2025 results on July 23. For second-quarter 2025, the Zacks Consensus Estimate for earnings is pegged at $2.13 per share, up by a penny over the past

Innodata INOD shares closed at $50.10 on Thursday, roughly 29.4% below the 52-week high of $71 it hit on Feb. 21, 2025. INOD shares have appreciated 26.8% year to date (YTD), outperforming the Zacks

At first glance, Green Dot Corporation GDOT appears to be a bargain. The stock is currently trading at just 7.99 times forward earnings, significantly below the industry average of 22.05. Such a low

Intuit Inc. INTU, the financial software leader behind TurboTax, QuickBooks, Credit Karma and Mailchimp, is doubling down on artificial intelligence (AI) to transform how individuals and businesses

NVR, Inc. NVR is expected to report lower earnings in the second quarter of 2025. Homebuilding revenues are also likely to have decreased on a year-over-year basis, given soft demand, elevated

Johnson & Johnson JNJ, on its second-quarter conference call, stated that it expects its oncology sales to reach $50 billion by the end of the decade.

Oncology, at present, comprises around 27% of

Pre-market futures are up again as a very eventful trading week winds to a close. The Dow is currently +0.12%, the S&P 500 is +0.09% and the Nasdaq +0.16% at this hour. The small-cap Russell 2000 is

Comerica Incorporated CMA has reported second-quarter 2025 adjusted earnings per share (EPS) of $1.42, beating the Zacks Consensus Estimate of $1.23. In the prior-year quarter, the company reported

Webster Financial WBS reported second-quarter 2025 earnings per share (EPS) of $1.52, which beat the Zacks Consensus Estimate of $1.41. Also, the reported figure compared favorably with the EPS of

Taiwan Semiconductor Manufacturing TSM reported robust second-quarter 2025 results, reflecting strength in AI and HPC-related demand, continued advanced node leadership and solid execution on global

D.R. Horton Inc. DHI is slated to report results for the third quarter of fiscal 2025 (ended June 30, 2025) on July 22, before the opening bell.In the last reported quarter that ended March 31

• (1:00) - Breaking Down The Current Unemployment Data: How Does This Impact The Economy?
• (7:50) - Are We Currently Heading Into A Recession or Can We Recover?
• (21:00) - How Should You Be Navigating

Netflix NFLX reported second-quarter 2025 earnings of $7.19 per share, which beat the Zacks Consensus Estimate by 1.7%. The figure jumped 47.3% from the year-ago quarter.Revenues came in slightly

Shares of F.N.B. Corporation FNB rose 2.3% in after-hours trading following the release of its second-quarter 2025 results. Earnings of 36 cents per share outpaced the Zacks Consensus Estimate of 33

Baker Hughes BKR is set to report second-quarter 2025 results on July 22, after the closing bell.

Let us delve into the factors that might have influenced BKR’s performance in the to-be-reported

3M Company MMM reported second-quarter 2025 results, wherein revenues and earnings surpassed the Zacks Consensus Estimate. It’s worth noting that in April 2024, the company completed the spin-off of

Investor excitement around D-Wave Quantum Inc. QBTS reached new highs this week after CNBC’s influencer market analyst Jim Cramer spotlighted the company on Mad Money, suggesting it was a compelling

Enphase Energy, Inc. (ENPH) is scheduled to report second-quarter 2025 results on July 22, 2025, after the closing bell.

Enphase Energy reported a negative earnings surprise in three of the trailing

GSK plc GSK announced that the FDA’s Oncologic Drugs Advisory Committee (ODAC) has voted against the overall benefit/risk profile of the Blenrep (belantamab mafodotin-blmf) combination therapy at